Companies: 10,795·Total market cap: $144.5T
Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUSOTCFinancial Services● Active
$0.00
$-0.00(-0.00%)
Market Cap$98773
P/E Ratio—
52W High$0.0111
52W Low$0.0025
Overview

Lotus Pharmaceuticals, Inc. (LTUS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001292087 · LTUS · OTC · as of Jun 9, 2026

Filing snapshot

169
Total Filings
8-K
Latest Form
2020-02-25
Most Recent
2005
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001292087 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2011-03-28
Fiscal Year End
Mar 28, 2011
Accession No.
0001161697-11-000268
Primary Document
form_10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001292087 · Accession 0001161697-11-000268

Latest Key Filings

10-QQuarterly Report
FORM 10-Q FOR 09-30-2011
2011-11-10
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2020-02-25Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2020-02-25
View
15-12G15-12G
FORM 15
2012-05-11
View
NT 10-KNT 10-K
FORM 12B-25 (NT 10-K) FOR 12-31-2011
2012-03-30
View
8-K/ACurrent Report (Amended)
FORM 8-K/A AMENDMENT NO. 1 FOR 12-31-2011
2012-03-15
View
8-KCurrent Report
FORM 8-K FOR 01-15-2012
2012-01-30
View
8-KCurrent Report
FORM 8-K FOR 01-03-2012
2012-01-11
View
8-KCurrent Report
FORM 8-K FOR 12-31-2011
2012-01-09
View
8-KCurrent Report
FORM 8-K FOR 11-11-2011
2011-11-16
View
10-QQuarterly Report
FORM 10-Q FOR 09-30-2011
2011-11-10
View
8-KCurrent Report
FORM 8-K FOR 08-15-2011
2011-08-17
View
10-QQuarterly Report
FORM 10-Q FOR 06-30-2011
2011-08-12
View
3Initial Statement of Beneficial Ownership
FORM 3
2011-05-26
View
3Initial Statement of Beneficial Ownership
FORM 3
2011-05-24
View
3Initial Statement of Beneficial Ownership
FORM 3
2011-05-24
View
3Initial Statement of Beneficial Ownership
FORM 3
2011-05-24
View
Showing 1–15 of 164 filingsForm 4 / 144 hidden· 169 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001292087  |  Exchange: OTC · Financial Services

Lotus Pharmaceuticals, Inc. (OTC: LTUS) has submitted 169 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2005. As a Financial Services sector company with CIK 0001292087, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lotus Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Lotus Pharmaceuticals, Inc. 10-K was filed on 2011-03-28 for fiscal year ending 2011. Historical LTUS 10-K annual reports are available from 2004 through 2011.

Investors researching Lotus Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Financial Services
ALDA SEC Filings →CHMJF SEC Filings →HBIE SEC Filings →AAPT SEC Filings →MNZO SEC Filings →VNTA SEC Filings →AWWI SEC Filings →AWON SEC Filings →
→ LTUS Financials→ LTUS Earnings→ LTUS Insider Trades

Frequently Asked Questions

LTUS SEC Filings · 8 questions

Lotus Pharmaceuticals, Inc. (LTUS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 169 filings and access original documents at no cost. Lotus Pharmaceuticals, Inc.'s CIK is 0001292087.

LTUS SEC filingsLotus Pharmaceuticals, Inc. SEC documentsfind LTUS 10-K